Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.
PHASE3
This is a randomized, double-blind, multicenter trial,parallel control desi...
A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma
PHASE2
This is a prospective, multicenter, single-arm, open phase II study to expl...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University